Browsing Tag
Roche
101 posts
Lonza to acquire Genentech’s biologics manufacturing facility in Vacaville for $1.2bn
In a strategic move that significantly escalates its capacity in the biologics manufacturing landscape, Lonza, a key global…
March 20, 2024
Roche to acquire LumiraDx’s Point of Care technology for $350m to expand diagnostics reach
Roche has announced a definitive agreement to acquire select parts of LumiraDx Group related to its innovative Point…
January 1, 2024
NiKang Therapeutics, Roche partner for advanced liver cancer treatment trial
NiKang Therapeutics Inc., a clinical-stage biotech company specializing in small molecule oncology medicines, has announced a significant clinical…
December 9, 2023
Genentech’s Phase 3 study of inavolisib in breast cancer reveals positive results
Genentech, part of the Roche Group, has presented compelling results from the Phase III INAVO120 study, evaluating the…
December 9, 2023
Roche’s inavolisib meets primary endpoint of PFS in Phase 3 breast cancer trial
Roche, a global leader in pharmaceuticals, announced positive results from its Phase III INAVO120 study, testing the investigational…
December 6, 2023
Roche to acquire Carmot Therapeutics to expand obesity treatment portfolio
Roche announced its definitive agreement to acquire Carmot Therapeutics, Inc., based in Berkeley, California, for an upfront purchase…
December 6, 2023
PsychoGenics secures license for ENT1 inhibitor RO7117997 from Roche
PGI Drug Discovery LLC (PsychoGenics), recognized for its phenotypic drug discovery platform, has announced an exclusive license agreement…
December 3, 2023
Roche’s Vabysmo gains FDA approval for treating retinal vein occlusion
Pharma giant Roche has secured the U.S. FDA’s approval for Vabysmo (faricimab) in treating macular edema after retinal…
October 28, 2023
Roche announces $7.1bn deal to acquire Telavant and RVT-3101 antibody
Switzerland-based Roche has officially declared its acquisition agreement for Telavant Holdings, Inc., a Roivant company collaboratively owned by…
October 23, 2023
Roche, Alnylam’s Zilebesiran meets primary endpoint in KARDIA-1 trial
Breaking news in the world of hypertension treatment, Roche and Alnylam Pharmaceuticals have announced the success of their…
September 10, 2023